US 11390603
Crystalline forms of a biphenyl compound
granted A61KA61K31/13A61K31/4545
Quick answer
US patent 11390603 (Crystalline forms of a biphenyl compound) held by Theravance Biopharma R&D IP, LLC expires Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue Jul 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/13, A61K31/4545, A61K31/56, A61K31/58